CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
41 hedge funds and large institutions have $40M invested in Carisma Therapeutics in 2015 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 7 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
66% less capital invested
Capital invested by funds: $119M → $40M (-$79.1M)
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.14M | |
| 2 | +$2.88M | |
| 3 | +$2.22M | |
| 4 |
O
OrbiMed
New York
|
+$2.06M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$245K |
Top Sellers
| 1 | -$8.62M | |
| 2 | -$3.47M | |
| 3 | -$2.66M | |
| 4 |
AC
Ascend Capital
Orinda,
California
|
-$1.87M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.75M |